Skip to main content

22nd Century Group, Inc.

corporate_fare Company Profile

22nd Century Group, Inc.

XXII·NASDAQ·Manufacturing·CIK 0001347858

22nd Century Group, Inc. is a tobacco products company focused on allowing cigarette smokers to control their nicotine consumption. The company manufactures and distributes combustible tobacco products with minimally or non-addictive nicotine levels, which are authorized by the US Food and Drug Administration (FDA) for retail sale. They also offer contract manufacturing services for cigarettes and filtered cigars to other tobacco brands. Their primary product, the VLN® cigarette, contains 95% less nicotine than traditional cigarettes and is designed to help reduce nicotine consumption. The company aims to provide adult smokers with the option to avoid addictive levels of nicotine. In December 2021, 22nd Century Group received Modified Risk Tobacco Product (MRTP) orders from the FDA for the marketing and sale of their RNC cigarettes, marking the first and only such orders for a combusted tobacco product.

22nd Century Group, Inc. (NASDAQ:XXII) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 40 items for XXII at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 10 rated 8 or above. Recent SEC coverage for XXII spans 10-Q, 8-K, 424B3, DEF 14A.

Recent high-impact activity:

  • 22nd Century 10-Q: Going-Concern Doubt Persists With $3.9M Cash After Q3 Revenue of $4.8M
  • 22nd Century Q3: Revenue Up 66% to $4.8M, Gross Profit Turns Positive at $0.4M
  • Q3 Revenue Jumps 66% Sequentially to $4.8M as Gross Profit Turns Positive
  • 22nd Century Sets 1-for-58 Reverse Split Effective Nov 5
  • 22nd Century Sets 1-for-58 Reverse Split Effective November 5 to Cure Nasdaq Deficiency

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$17.59M
Net Income
-$5.05M
Diluted EPS
-$52.87
Op. Cash Flow
-$7.72M
Free Cash Flow
-$7.78M
Gross Profit
$7.4M
Operating Income
-$11.57M
Cash & Equivalents
$7.15M
Total Debt
$708K
Debt / Equity
0.04×
Net Margin
-28.7%
Shares Outstanding
510.38K sh
Source: 10-K · filed 2026-03-26 · accession 0001104659-26-034814

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,198,947 shares in XXII as of the October 30, 2026 settlement, a 3074.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 55.8% of XXII volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,198,947 shares as of October 30, 2026
Change vs prior period▲ 3074.8%
Days to cover1.00 at avg daily volume of 63,446,721
Daily short volume (FINRA facilities)55.8% of 717,220 shares on November 20, 2026
5-day average short volume55.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for XXII, detected from its recent SEC filings · based on capital-structure filings through 2026-10-28.

2 recent capital raisesATM program1 shelf registrationreverse split

Warrant Exercise Price Slashed 91% · Cashless Exercise Now Allowed

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with X →
$0.3112 -7.52% today
52-week range · as of 2026-11-16 $0.3112 – $20314.46
Market cap
$185.36K
Volume
1.7M (0.7× avg)
3-mo avg 2.6M
Live data · 2026-11-22 08:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XXII - Latest Insights

XXII
Nov 16, 2026, 6:31 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7208
Real-time Price: $0.3112 info
Change: -$0.4096 (-57%) info
Market Cap: $185.364K info
XXII
Nov 16, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.690
Real-time Price: $0.3112 info
Change: -$0.3788 (-55%) info
Market Cap: $185.364K info
XXII
Nov 16, 2026, 6:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.3112 info
Change: -$0.3989 (-56%) info
Market Cap: $185.364K info
XXII
Nov 03, 2026, 12:35 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.0565
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Nov 03, 2026, 11:40 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.06355
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Oct 23, 2026, 6:22 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.1359
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Oct 23, 2026, 5:23 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1942
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Oct 22, 2026, 10:36 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.3436
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Oct 22, 2026, 10:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3436
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Sep 28, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.39
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Aug 14, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Aug 14, 2026, 4:13 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Aug 13, 2026, 6:14 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Aug 13, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Jul 02, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.01
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Jun 26, 2026, 4:15 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $3.93
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Jun 23, 2026, 5:23 PM EDT
Filing Type: DEF 14A
Importance Score:
10
Price at Filing: $4.70
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Jun 12, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $6.52
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Jun 12, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $6.51
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
XXII
Jun 09, 2026, 9:28 AM EDT
Filing Type: 8-K/A
Importance Score:
9
Price at Filing: $0.4309
Real-time Price: $0.3112 info
Change: Reverse Stock Split info
Market Cap: $185.364K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets